Yamamoto Yukio, Moore Rick, Hess Holly A, Guo Grace L, Gonzalez Frank J, Korach Kenneth S, Maronpot Robert R, Negishi Masahiko
Laboratories of Reproductive and Developmental Toxicology, NIEHS/National Institutes of Health, Research Triangle Park, NC 27709, USA.
J Biol Chem. 2006 Jun 16;281(24):16625-31. doi: 10.1074/jbc.M602723200. Epub 2006 Apr 10.
Estrogens are known to cause hepatotoxicity such as intrahepatic cholestasis in susceptible women during pregnancy, after administration of oral contraceptives, or during postmenopausal replacement therapy. Enterohepatic nuclear receptors including farnesoid X receptor (FXR), pregnane X receptor (PXR), and constitutive active/androstane receptor (CAR) are important in maintaining bile acid homeostasis and protecting the liver from bile acid toxicity. However, no nuclear receptor has been implicated in the mechanism for estrogen-induced hepatotoxicity. Here Era(-/-), Erb(-/-), Fxr(-/-), Pxr(-/-), and Car(-/-) mice were employed to show that Era(-/-) mice were resistant to synthetic estrogen 17alpha-ethynylestradiol (EE2)-induced hepatotoxicity as indicated by the fact that the EE2-treated Era(-/-) mice developed none of the hepatotoxic phenotypes such as hepatomegaly, elevation in serum bile acids, increase of alkaline phosphatase activity, liver degeneration, and inflammation. Upon EE2 treatment, estrogen receptor alpha (ERalpha) repressed the expression of bile acid and cholesterol transporters (bile salt export pump (BSEP), Na(+)/taurocholate cotransporting polypeptide (NTCP), OATP1, OATP2, ABCG5, and ABCG8) in the liver. Consistently, biliary secretions of both bile acids and cholesterol were markedly decreased in EE2-treated wild-type mice but not in the EE2-treated Era(-/-) mice. In addition, ERalpha up-regulated the expression of CYP7B1 and down-regulated the CYP7A1 and CYP8B1, shifting bile acid synthesis toward the acidic pathway to increase the serum level of beta-muricholic acid. ERbeta, FXR, PXR, and CAR were not involved in regulating the expression of bile acid transporter and biosynthesis enzyme genes following EE2 exposure. Taken together, these results suggest that ERalpha-mediated repression of hepatic transporters and alterations of bile acid biosynthesis may contribute to development of the EE2-induced hepatotoxicity.
已知雌激素会在易感女性孕期、口服避孕药后或绝经后激素替代治疗期间导致肝毒性,如肝内胆汁淤积。包括法尼酯X受体(FXR)、孕烷X受体(PXR)和组成型活性/雄甾烷受体(CAR)在内的肠肝核受体在维持胆汁酸稳态及保护肝脏免受胆汁酸毒性方面起着重要作用。然而,尚无核受体与雌激素诱导的肝毒性机制相关。在此,使用Era(-/-)、Erb(-/-)、Fxr(-/-)、Pxr(-/-)和Car(-/-)小鼠来表明,Era(-/-)小鼠对合成雌激素17α-乙炔雌二醇(EE2)诱导的肝毒性具有抗性,这体现在经EE2处理的Era(-/-)小鼠未出现任何肝毒性表型,如肝肿大、血清胆汁酸升高、碱性磷酸酶活性增加、肝脏变性和炎症。经EE2处理后,雌激素受体α(ERα)抑制肝脏中胆汁酸和胆固醇转运蛋白(胆盐输出泵(BSEP)、Na(+)/牛磺胆酸盐共转运多肽(NTCP)、OATP1、OATP2、ABCG5和ABCG8)的表达。同样,经EE2处理的野生型小鼠胆汁酸和胆固醇的胆汁分泌显著减少,而经EE2处理的Era(-/-)小鼠则未减少。此外,ERα上调CYP7B1的表达并下调CYP7A1和CYP8B1,使胆汁酸合成向酸性途径转变,从而增加β-鼠胆酸的血清水平。ERβ、FXR、PXR和CAR在EE2暴露后不参与调节胆汁酸转运蛋白和生物合成酶基因的表达。综上所述,这些结果表明,ERα介导的肝脏转运蛋白抑制和胆汁酸生物合成改变可能导致EE2诱导的肝毒性的发生。